MedTrace Logo

Lipid Lowering in Patients With Statin Intolerance

NCT00405769 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2007-10-31

No results posted yet for this study

Summary

This study will attempt to further validate a clinical treatment plan to lower LDL values using non-prescription supplements combined with a lifestyle change and education program which could represent an alternative approach to improve compliance in group of people who are unable to take traditional medication to lower cholesterol.

Conditions

Interventions

DRUG

red yeast rice

600 mg 3 caps bid

DRUG

placebo

3 caps bid

Sponsors & Collaborators

  • Chestnut Hill Health System

    lead OTHER

Principal Investigators

  • David J Becker, MD · Chestnut Hill Health System

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Completion
2007-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00405769 on ClinicalTrials.gov